Santiago-Walker Ademi E, Fikaris Aphrothiti J, Kao Gary D, Brown Eric J, Kazanietz Marcelo G, Meinkoth Judy L
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, 19104-6061, USA.
J Biol Chem. 2005 Sep 16;280(37):32107-14. doi: 10.1074/jbc.M504432200. Epub 2005 Jul 28.
Overexpression of protein kinase C delta (PKCdelta) stimulates apoptosis in a wide variety of cell types through a mechanism that is incompletely understood. PKCdelta-deficient cells are impaired in their response to DNA damage-induced apoptosis, suggesting that PKCdelta is required to mount an appropriate apoptotic response under conditions of stress. The mechanism through which it does so remains elusive. In addition to effects on cell survival, PKCdelta elicits pleiotropic effects on cellular proliferation. We now provide the first evidence that the ability of PKCdelta to stimulate apoptosis is intimately linked to its ability to stimulate G(1) phase cell cycle progression. Using an adenoviral-based expression system to express PKCalpha,-delta, and -epsilon in epithelial cells, we demonstrate that a modest increase in PKCdelta activity selectively stimulates quiescent cells to initiate G(1) phase cell cycle progression. Rather than completing the cell cycle, PKCdelta-infected cells arrest in S phase, an event that triggers caspase-dependent apoptotic cell death. Apoptosis was preceded by the activation of cell cycle checkpoints, culminating in the phosphorylation of Chk-1 and p53. Strikingly, blockade of S phase entry using the phosphatidylinositol 3-kinase inhibitor LY294002 prevented checkpoint activation and apoptosis. In contrast, inhibitors of mitogen-activated protein kinase cascades failed to prevent apoptosis. These findings demonstrate that the biological effects of PKCdelta can be extended to include positive regulation of G(1) phase cell cycle progression. Importantly, they reveal the existence of a novel, cell cycle-dependent mechanism through which PKCdelta stimulates cell death.
蛋白激酶Cδ(PKCδ)的过表达通过一种尚未完全理解的机制在多种细胞类型中刺激细胞凋亡。PKCδ缺陷型细胞对DNA损伤诱导的细胞凋亡反应受损,这表明在应激条件下,PKCδ是产生适当凋亡反应所必需的。其作用机制仍然难以捉摸。除了对细胞存活的影响外,PKCδ还对细胞增殖产生多效性作用。我们现在提供了首个证据,证明PKCδ刺激细胞凋亡的能力与其刺激G1期细胞周期进程的能力密切相关。使用基于腺病毒的表达系统在上皮细胞中表达PKCα、-δ和-ε,我们证明PKCδ活性的适度增加选择性地刺激静止细胞启动G1期细胞周期进程。PKCδ感染的细胞不是完成细胞周期,而是停滞在S期,这一事件触发了半胱天冬酶依赖性的凋亡性细胞死亡。细胞凋亡之前是细胞周期检查点的激活,最终导致Chk-1和p53的磷酸化。引人注目的是,使用磷脂酰肌醇3-激酶抑制剂LY294002阻断S期进入可防止检查点激活和细胞凋亡。相反,丝裂原活化蛋白激酶级联反应的抑制剂未能阻止细胞凋亡。这些发现表明,PKCδ的生物学效应可以扩展到包括对G1期细胞周期进程的正向调节。重要的是,它们揭示了一种新的、依赖细胞周期的机制,通过该机制PKCδ刺激细胞死亡。